|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/433 | |
| A61K 31/501 | |||
| A61K 31/4245 | |||
| A61P 31/12 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 3277276 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16774100.8 |
| Date of filing the European patent application | 2016-03-30 | |
| (97) | Date of publication of the European application | 2018-02-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/024998 |
| Date | 2016-03-30 |
| (87) | Number | WO 2016/160980 |
| Date | 2016-10-06 |
| (30) | Number | Date | Country code |
| 201562139928 P | 2015-03-30 | US | |
| 201562168112 P | 2015-05-29 | US |
| (72) |
GROSS, Matthew I., US
BENNETT, Mark, K., US
MOLINEAUX, Christopher, US
|
| (73) |
Calithera Biosciences, Inc.,
343 Oyster Point Boulevard Suite 200, South San Francisco, CA 94080,
US
|
| (54) | METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS |
| METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS |